Document Detail

A comparison between secretin alone and sequential and simultaneous secretin and cholecystokinin administration in the assessment of pancreatic function.
MedLine Citation:
PMID:  4455566     Owner:  NLM     Status:  MEDLINE    
Pancreatic volume, bicarbonate and enzyme secretion were studied after sequential and after simultaneous secretin and cholecystokinin (CCK) stimulation and the results compared. No statistical difference between sequential or simultaneous stimulation was noted. A comparison of secretin alone with simultaneous secretin plus cholecystokinin stimulation showed that the combination yielded a significantly higher trypsin concentration. Volume and bicarbonate were unchanged.
J Clain; S Bank; G O Barbezat; B H Novis; I N Marks
Related Documents :
2930766 - The rabbit as an animal model of hepatic lipase deficiency.
950076 - Exocrine pancreatic function in man after treatment with oxytetracycline and chloramphe...
9720246 - Staphylococcal lipases: molecular characterisation, secretion, and processing.
2996326 - Effects of dietary fibers and cholestyramine on the activity of pancreatic lipase in vi...
23969526 - Hyaluronan degrading silica nanoparticles for skin cancer therapy.
3929276 - Enhanced prostacyclin biosynthesis and decreased thromboxane formation by 3-dimethylami...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Gut     Volume:  15     ISSN:  0017-5749     ISO Abbreviation:  Gut     Publication Date:  1974 Nov 
Date Detail:
Created Date:  1975-06-21     Completed Date:  1975-06-21     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  2985108R     Medline TA:  Gut     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  885-8     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bicarbonates / analysis
Cholecystokinin / diagnostic use*
Pancreas / drug effects,  physiopathology,  secretion
Pancreatic Diseases / diagnosis*
Secretin / diagnostic use*
Reg. No./Substance:
0/Bicarbonates; 1393-25-5/Secretin; 9011-97-6/Cholecystokinin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Duodenal reflux during insulin-stimulated secretion.
Next Document:  The role of secretin in the inhibition of gastric secretion by intraduodenal acid.